Literature DB >> 15129715

99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: methodological considerations.

Michael Gabriel, Clemens Decristoforo, Moncayo Roy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15129715     DOI： 10.1007/s00259-003-1383-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

1.  99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.

Authors:  C Decristoforo; S J Mather; W Cholewinski; E Donnemiller; G Riccabona; R Moncayo
Journal:  Eur J Nucl Med       Date:  2000-09

2.  An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.

Authors:  Michael Gabriel; Clemens Decristoforo; Eveline Donnemiller; Hanno Ulmer; Christine Watfah Rychlinski; Stephen J Mather; Roy Moncayo
Journal:  J Nucl Med       Date:  2003-05       Impact factor: 10.057

3.  Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.

Authors:  Rachida Lebtahi; Joseph Le Cloirec; Claire Houzard; Doumit Daou; Iradj Sobhani; Geneviève Sassolas; Michel Mignon; Patrick Bourguet; Dominique Le Guludec
Journal:  J Nucl Med       Date:  2002-07       Impact factor: 10.057
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.